Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sotera Health ( (SHC) ) just unveiled an announcement.
On February 4, 2026, Sotera Health Company expanded its Board of Directors from eleven to twelve members and appointed former Timken chief executive Richard G. Kyle as a Class III director, with immediate effect. Kyle, an experienced industrial executive who led Timken’s financial transformation and strategic diversification between 2014 and 2024 and who also serves on the boards of Timken and Sonoco Products Company, has been designated an independent director and will sit on Sotera Health’s Leadership Development and Compensation Committee as well as its Nominating and Corporate Governance Committee, signaling a move to bolster the company’s governance, strategic oversight, and executive-compensation stewardship through seasoned industrial and operational expertise.
The most recent analyst rating on (SHC) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
The score is driven primarily by mixed financial fundamentals (strong gross margins but high leverage and weakening free cash flow), supported by a strong uptrend in the stock. Earnings call guidance and execution were constructive (growth, margin expansion, and debt paydown), but the overall rating is capped by a very high P/E valuation and ongoing operational/litigation risks.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Average Trading Volume: 2,439,585
Technical Sentiment Signal: Buy
Current Market Cap: $5.07B
Find detailed analytics on SHC stock on TipRanks’ Stock Analysis page.